Citations

Showing 10 of 108162 citations.

Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes
Waller, Rosalie, McKay, James , Clay‐Gilmour, Alyssa , Wei, Xiaomu , Madsen, Michael J. , Sborov, Douglas W. , Curtin, Karen , Slager, Susan L, Offit, Kenneth , Vachon, Celine M. , Lipkin, Steven M. , Camp, Nicola J. , Waller, Rosalie G. , Griffin, R. L. , Clay-Gilmour, Alyssa, Waller, Rosalie G , Griffin, Rosalie , Klein, Robert J. , Vijai, Joseph , Vachon, Celine M. , Dumontet, Charles

Mayo Clinic

Human Molecular Genetics | March 2, 2021 | Volume: 30 | Issue: 12 | Pages: 1142-1153

10.1093/hmg/ddab066 | PMID 33751038 Get It

Abstract Inherited genetic risk factors play a role in multiple myeloma (MM), yet considerable missing heritability exists. Rare risk variants at genome-wide association study (GWAS) loci are a new avenue to explore. Pleiotropy between lymphoid neoplasms (LNs) has been suggested in family history and genetic studies, but no studies have interrogated sequencing for pleiotropic genes or rare risk variants. Sequencing genetically enriched cases can help discover rarer variants. We analyzed exome sequencing in familial or early-onset MM cases to identify rare, functionally relevant variants near GWAS loci for a range of LNs. A total of 149 distinct and significant LN GWAS loci have been published. We identified six recurrent, rare, potentially deleterious variants within 5 kb of significant GWAS single nucleotide polymorphisms in 75 MM cases. Mutations were observed in BTNL2, EOMES, TNFRSF13B, IRF8, ACOXL and TSPAN32. All six genes replicated in an independent set of 255 early-onset MM or familial MM or precursor cases. Expansion of our analyses to the full length of these six genes resulted in a list of 39 rare and deleterious variants, seven of which segregated in MM families. Three genes also had significant rare variant burden in 733 sporadic MM cases compared with 935 control individuals: IRF8 (P = 1.0 × 10−6), EOMES (P = 6.0 × 10−6) and BTNL2 (P = 2.1 × 10−3). Together, our results implicate six genes in MM risk, provide support for genetic pleiotropy between LN subtypes and demonstrate the utility of sequencing genetically enriched cases to identify functionally relevant variants near GWAS loci.
Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation of Utility in a Typical Clinical Practice
Hall, S. , Thiriveedi, Mrudula , Yandrapalli, Usha , Zhang, Nan , Yendrapalli, U. , Hall, Scott R , Lott, David G , Lott, David G.

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | March 2, 2021 | Volume: 130 | Issue: 10 | Pages: 1164-1170

10.1177/0003489421998215 | PMID 33648353 Get It

Objectives: The goal of this study was to evaluate the benefit of sublesional bevacizumab injection for recurrent respiratory papillomatosis (RRP) as used in a typical clinical practice. Methods: A retrospective review of patients with RRP treated between 2011 and 2016 was undertaken. All patients were treated with in-office potassium titanyl phosphate (KTP) laser photoablation. Sublesional bevacizumab injection was used based on joint patient-physician decision making. Papilloma burden was objectively measured on prior recordings by 2 blinded reviewers and described as vocal fold segments affected (VFSA) by papilloma. Each patient served as their own control by comparing times when bevacizumab was or was not used. Mixed model for longitudinal data was used to determine if the previous use of bevacizumab decreased the disease burden. Results: A total of 19 patients met inclusion criteria and all prior laryngoscopic exams were reviewed for VFSA as described above. The mean (SD) number of VFSA when bevacizumab was not used at the prior procedure was 15 (14) as compared to 8 (11) when bevacizumab was used. When adjusted for age, time from initial presentation and baseline disease burden, mixed model showed a decrease of 11 VFSA (95% CI 6.5, 15.5, P < .0001) when bevacizumab was used as compared to when bevacizumab was not used at the prior procedure. In mixed model analysis, there was not a significant association between bevacizumab dose used and VFSA at the subsequent visit ( P = .8). Conclusion: Using sublesional bevacizumab intermittently based on clinical findings appears to be effective in improving disease control. Papilloma burden is significantly decreased at the subsequent clinical follow-up following injection of sublesional bevacizumab. The beneficial effect of sublesional bevacizumab may be not be dose-dependent.
Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A+T+) in a population‐based sample
Alden, Eva , Pudumjee, Shehroo B. , Lundt, Emily S. , Albertson, Sabrina M., Kremers, Walter K. , Petersen, Ronald C. , Alden, Eva C, Stricker, Nikki H. , Kremers, Walter K , Machulda, Mary M. , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M. , Lundt, Emily S

Mayo Clinic

Alzheimer's & Dementia | March 2, 2021 | Volume: 17 | Issue: 4 | Pages: 584-594

10.1002/alz.12219 | PMID 33650308 Get It

AbstractIntroductionThis study evaluated the diagnostic accuracy of the Cogstate Brief Battery (CBB) for mild cognitive impairment (MCI) and prodromal Alzheimer's disease (AD) in a population‐based sample.MethodsParticipants included adults ages 50+ classified as cognitively unimpaired (CU, n = 2866) or MCI (n = 226), and a subset with amyloid (A) and tau (T) positron emission tomography who were AD biomarker negative (A–T–) or had prodromal AD (A+T+).ResultsDiagnostic accuracy of the Learning/Working Memory Composite (Lrn/WM) for discriminating all CU and MCI was moderate (area under the curve [AUC] = 0.75), but improved when discriminating CU A–T– and MCI A+T+ (AUC = 0.93) and when differentiating MCI participants without AD biomarkers from those with prodromal AD (AUC = 0.86). Conventional cut‐offs yielded lower than expected sensitivity for both MCI (38%) and prodromal AD (73%).DiscussionClinical utility of the CBB for detecting MCI in a population‐based sample is lower than expected. Caution is needed when using currently available CBB normative data for clinical interpretation.
A Panel Evaluation of the Changes in the General Public’s Social-Media-Following of United States’ Public Health Departments during COVID-19 Pandemic
Khokhar, Areej, Spaulding, Aaron , Niazi, Zuhair, Chanan‐Khan, Asher , Niazi, Shehzad K. , Sher, Taimur , Manochakian, Rami , Chanan-Khan, Asher, Niazi, Shehzad, Sher, Taimur , Spaulding, Aaron , Ailawadhi, Sikander

Mayo Clinic

Journal of Primary Care & Community Health | March 2, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/2150132721995450 | PMID 33648364 Get It

Importance: Social media is widely used by various segments of society. Its role as a tool of communication by the Public Health Departments in the U.S. remains unknown. Objective: To determine the impact of the COVID-19 pandemic on social media following of the Public Health Departments of the 50 States of the U.S. Design, Setting, and Participants: Data were collected by visiting the Public Health Department web page for each social media platform. State-level demographics were collected from the U.S. Census Bureau. The Center for Disease Control and Prevention was utilized to collect information regarding the Governance of each State’s Public Health Department. Health rankings were collected from “America’s Health Rankings” 2019 Annual report from the United Health Foundation. The U.S. News and World Report Education Rankings were utilized to provide information regarding the public education of each State. Exposure: Data were pulled on 3 separate dates: first on March 5th (baseline and pre-national emergency declaration (NED) for COVID-19), March 18th (week following NED), and March 25th (2 weeks after NED). In addition, a variable identifying the total change across platforms was also created. All data were collected at the State level. Main Outcome: Overall, the social media following of the state Public Health Departments was very low. There was a significant increase in the public interest in following the Public Health Departments during the early phase of the COVID-19 pandemic. Results: With the declaration of National Emergency, there was a 150% increase in overall public following of the State Public Health Departments in the U.S. The increase was most noted in the Midwest and South regions of the U.S. The overall following in the pandemic “hotspots,” such as New York, California, and Florida, was significantly lower. Interesting correlations were noted between various demographic variables, health, and education ranking of the States and the social media following of their Health Departments. Conclusion and Relevance: Social media following of Public Health Departments across all States of the U.S. was very low. Though, the social media following significantly increased during the early course of the COVID-19 pandemic, but it still remains low. Significant opportunity exists for Public Health Departments to improve social media use to engage the public better.
Association Between Baseline Meniscal Symptoms and Outcomes of Operative and Nonoperative Treatment of Meniscal Tear in Patients With Osteoarthritis
MacFarlane, Lindsey A. , Yang, Heidi Y. , Collins, Jamie E. , Brophy, Robert H. , Cole, Brian J. , Mandl, Lisa A. , Marx, Robert G. , Levy, Bruce A. , Safran‐Norton, Clare E., Wright, John, Wright, Rick W. , Mandl, Lisa A , Losina, Elena , Brophy, Robert H. , Collins, Jamie E , Spindler, Kurt P , Guermazi, Ali , Jones, Morgan H. , Martin, Scott D. , Marx, Robert G. , Stuart, Michael J. , Losina, Elena , Katz, Jeffrey N.

Mayo Clinic

Arthritis Care & Research | March 2, 2021 | Volume: 74 | Issue: 8 | Pages: 1384-1390

10.1002/acr.24588 | PMID 33650303 Get It

ObjectivePatients with meniscal tears reporting meniscal symptoms such as catching or locking have traditionally undergone arthroscopy. The present study was undertaken to investigate whether patients with meniscal tears who report meniscal symptoms have greater improvement with arthroscopic partial meniscectomy (APM) than physical therapy (PT).MethodsWe used data from the Meniscal Tear in Osteoarthritis Research (MeTeOR) trial, which randomized participants with knee osteoarthritis (OA) and meniscal tear to APM or PT. The frequency of each meniscal symptom (clicking, catching, popping, intermittent locking, giving way, swelling) was measured at baseline and 6 months. We used linear regression models to determine whether the difference in improvement in Knee Injury and Osteoarthritis Outcome Score (KOOS) pain score at 6 months between patients treated with APM versus PT was modified by the presence of each meniscal symptom. We also determined the percentage of participants with resolution of meniscal symptoms by treatment group.ResultsWe included 287 participants. The presence (versus absence) of any of the meniscal symptoms did not modify the improvement in KOOS pain score between APM versus PT by >0.5 SD (all P interaction >0.05). APM led to greater resolution of intermittent locking and clicking than PT (locking 70% versus 46%, clicking 41% versus 25%). No difference in resolution of the other meniscal symptoms was observed.ConclusionMeniscal symptoms were not associated with improved pain relief. Although symptoms of clicking and intermittent locking had a greater reduction in the APM group, the presence of meniscal symptoms in isolation should not inform clinical decisions surrounding APM versus PT in patients with meniscal tear and knee OA.
Cardiac Rehabilitation Referral and Participation Rates for Heart Failure With Reduced Ejection Fraction
Ding, Rongjing , Medina‐Inojosa, José R. , Zhang, Sisi , Supervía, Marta , Squires, Ray W. , Olson, Thomas P. , Leth, Shawn , Lin, Grace , Smith, Joshua R. , Leth, Shawn E, Smith, Joshua R , Medina-Inojosa, José R , Smith, Joshua R., Fischer, Karen M. , Zhang, Wenliang , Thomas, Randal J.

Mayo Clinic

Journal of Cardiopulmonary Rehabilitation and Prevention | March 2, 2021 | Volume: 41 | Issue: 2 | Pages: 126-127

10.1097/hcr.0000000000000589 | PMID 33647922 Get It

Development of a Conceptual Framework of Patient-reported Outcomes in Light Chain Amyloidosis: A Qualitative Study
D’Souza, Anita , Myers, Judith, Finkel, Muriel , Panepinto, Julie A., D'Souza, Anita , Cusatis, Rachel , Dispenzieri, Angela , Panepinto, Julie A. , Flynn, Kathryn E.

Mayo Clinic

No container title available | March 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-272559/v1 Get It

Abstract Background Light chain (AL) amyloidosis is a plasma cell neoplasm associated with high early mortality and severe morbidity that can cause severe disability. We explored the impact of AL amyloidosis on symptoms and well-being from the perspectives of patients and health care providers who regularly care for AL patients. We intended to develop a conceptual understanding of patient-reported outcomes in AL amyloidosis to identify the context of use and concept of interest for a clinical outcome assessments tool in this disease.Method Twenty patients and 10 professionals were interviewed. Patient interviews captured the spectrum of amyloidosis experience including time from diagnosis, type of organ involvement, and presence and type of treatment received. Interviews with professionals included physicians, advanced practice providers, registered nurse, and a patient advocate; these interviews covered similar topics. Results The impact of AL amyloidosis on patients’ life was multidimensional, with highly subjective perceptions of normality and meaning. Four major themes from patients and experts included diagnosis of AL amyloidosis, living with AL amyloidosis, symptom burden, and social roles. Barriers to patient-reported outcomes data collection in patients were additionally explored from experts. The themes provide a comprehensive understanding of the important experiences of symptom burden and its impact on daily life from AL amyloidosis patients’ and from the perspectives of professionals who care for patients with AL amyloidosis. Conclusion These findings further the conceptual understanding and identification of a preliminary model of concept of interest for development of a clinical outcome assessments tool for AL amyloidosis.
Increasing Utility of Google Trends in Monitoring Cardiovascular Disease
Senecal, Conor , Lerman, Lilach O. , Mahowald, Madeline , López-Jiménez, Francisco , Lerman, Amir

Mayo Clinic

No container title available | March 1, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-251637/v1 Get It

Abstract Introduction: Cardiovascular disease is the most common cause of morbidity and mortality in the United States and in the world. Patients are increasingly using internet search to find health-related information, including searches for cardiovascular diseases and risk factors. We sought to evaluate the change in the state by state correlation of cardiovascular disease and risk factors with Google Trends search volumes. Methods: Data on cardiovascular disease hospitalizations and risk factor prevalence were obtained from the publically available CDC website from 2006-2018. Google Trends data were obtained for matching conditions and time periods. Simple linear regression was performed to evaluate for an increase in correlation over time. Results: Hospitalizations for six separate cardiovascular disease conditions showed moderate to strong correlation with online search data in the last period studied (heart failure (0.58, P<0.001), atrial fibrillation (0.57, P<0.001), coronary heart disease (0.58, P<0.001), myocardial infarction (0.70, P<0.001), stroke (0.62, P<0.001), cardiac dysrhythmia (0.46, P<0.001)). All diseases studied showed a positive increase in correlation throughout the time period studied (P<0.05). All five of the cardiovascular risk factors studied showed strong correlation with online search data; diabetes (R=0.78, P<0.001), cigarette use (R=0.79, P<0.001), hypertension (R=0.81, P<0.001), high cholesterol (R=0.59, P<0.001), obesity (R=0.80, P<0.001). Three of the five showed an increasing correlation over time. Conclusion: The prevalence of and hospitalizations for cardiovascular conditions in the United States strongly correlate with online search volumes nationwide and when analyzed by state. This relationship has progressively strengthened or been strong and stable over recent years for these conditions. Google Trends represents an increasingly valuable tool for evaluating the burden of cardiovascular disease and risk factors in the United States.
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies
Jacobsen, Elizabeth A. , Heffler, Enrico , Mathur, Sameer K. , Bredenoord, Albert J. , Akuthota, Praveen , Roufosse, Florence , Jacobsen, Elizabeth A , Jackson, David J. , Pavord, Ian Douglas , Rothenberg, Marc E.

Mayo Clinic

Annual Review of Immunology | March 1, 2021 | Volume: 39 | Issue: 1 | Pages: 719-757

10.1146/annurev-immunol-093019-125918 | PMID 33646859 Get It

The enigmatic eosinophil has emerged as an exciting component of the immune system, involved in a plethora of homeostatic and inflammatory responses. Substantial progress has been achieved through experimental systems manipulating eosinophils in vivo, initially in mice and more recently in humans. Researchers using eosinophil knockout mice have identified a contributory role for eosinophils in basal and inflammatory processes and protective immunity. Primarily fueled by the purported proinflammatory role of eosinophils in eosinophil-associated diseases, a series of anti-eosinophil therapeutics have emerged as a new class of drugs. These agents, which dramatically deplete eosinophils, provide a valuable opportunity to characterize the consequences of eosinophil knockout humans. Herein, we comparatively describe mouse and human eosinophil knockouts. We put forth the view that human eosinophils negatively contribute to a variety of diseases and, unlike mouse eosinophils, do not yet have an identified role in physiological health; thus, clarifying all roles of eosinophils remains an ongoing pursuit.
Delayed Craniospinal Metastasis of Aggressive Nonfunctioning Pituitary Adenomas as Pituitary Carcinomas
Raghu, Ashley L. B. , Everson, Megan C., Helal, Ahmed , Kiyofuji, Satoshi , Link, Michael J. , Clarke, Michelle J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 1, 2021 | Volume: 83 | Issue: S 02 | Pages: e253-e259

10.1055/s-0041-1725024 | PMID 35832993 Get It

Abstract Background Clinical behavior of pituitary neoplasms is peculiar and notoriously difficult to predict. While aggressive tumors are common, metastasis is very rare, can be highly delayed, and there are no histological or clinical features to meaningfully predict this happening. Endocrinologically silent tumors are particularly difficult, as there is less opportunity to detect early metastasis. Together, this amounts to a situation of uncertainty over the appropriate management of such tumors before and after metastasis. Case Description The authors report two cases of nonfunctioning aggressive pituitary adenoma (APA) each requiring two transsphenoidal surgeries, a transcranial resection and radiotherapy. Both these tumors subsequently metastasized caudally along the neuraxis, years later, as a null cell carcinoma associated with a germline CHEK2 mutation and a silent Crooke's cell carcinoma. The former represents a novel oncogenetic association. Conclusion Delayed drop dural metastasis of pituitary carcinoma is becoming increasingly recognized. Surgical resection of the distant disease to confirm the diagnosis and relieve the mass effect, followed by temozolomide chemotherapy, is the current treatment of choice. The need for both long-term follow-up in patients with APA, and a high degree of suspicion toward dural-based radiographic findings is emphasized.